A familiar firm name is a starting point. Check who bought, sold or invested, which business was involved, and what the source says happened. Search reviewed acquisitions, combinations and ownership events below.
Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.
Researching adviser acquisitions?
Start with supported buyer roles in the acquirer directory, then check each event’s status and original sources.
Choose the activity: an adviser transaction and a portfolio-company deal describe different businesses.
Check each party’s role. An investor in a firm is not necessarily that firm’s acquisition target.
Read the reported status and date basis. An announcement does not establish a closing date.
Open the transaction for reviewed sources and links to the identified adviser profiles.
Catalog-wide coverage: 1,553 canonical transactions; 720 classified, 833 unclassified. Adviser / wealth-management: 183 · Portfolio-company: 526 · Other business activity: 11 · Activity not yet classified: 833. These counts cover the entire eligible catalog, not the filtered results or the whole market.
1,553 reviewed transactions in these results. Missing dates sort last.
Cinven and CVC announced that KKR would invest as a new shareholder in NewDay Operating Group while they remained invested. The equity investment formed part of a wider transaction that also separated NewDay's consumer-credit receivables from its origination and servicing business. Completion was anticipated at the end of September 2025, subject to customary conditions; the equity percentage was not disclosed.
Garden City Equity reported that its Commercial Residential Aluminum portfolio company acquired American Lightscapes, a landscape-lighting and design business. A separate closing date was not stated.
Paladin Capital Group reported that its portfolio company CalypsoAI agreed to be acquired by F5 for $180 million. Paladin had first invested through Cyber Fund II in 2020 and participated in follow-on financing. The release described an upcoming acquisition and did not establish completion.
Cinven announced an agreement for its funds to invest in Grant Thornton Germany alongside existing equity partners. The partnership remained subject to partner approval, regulatory approvals and customary closing conditions.
Glynn Capital was named among investors in a proposed common-stock PIPE of more than $125 million associated with Infleqtion’s planned combination with Churchill Capital Corp X. The September 8, 2025 report described the transaction as conditional. The total is the entire PIPE, not Glynn’s contribution; existing Infleqtion shareholders were not selling shares.
Rithm Capital reported completion of its acquisition of Crestline Management, L.P. on December 1, 2025, following the September 4 agreement. The completion report does not state the exact closing day.
Hunter Point Capital and Temasek announced minority investments in Nuveen Private Capital as part of a strategic partnership on September 3, 2025. Nuveen would maintain majority ownership, while Churchill and Arcmont senior management and employees retained minority stakes. Temasek’s commitments to investment strategies were separate from the ownership investments; an exact closing day and ownership percentages were not reported.
Remedy Meds announced an all-stock agreement to acquire HealthQuest portfolio company Thirty Madison. Closing was expected in the fourth quarter of 2025, subject to customary conditions and regulatory review. No exact closing date is assigned.
Syndigo reported acquiring 1WorldSync, with the combined business backed by Summit Partners, TJC and Battery Ventures. Summit Partners is attributed as sponsor-manager; the report does not state the exact closing day.
Pension & Wealth Management Advisors reported acquiring Devonshire Asset Management Inc., an advisory practice in Winchester, Massachusetts. The founders were to continue serving their client relationships with the PWMA team; no separate closing date was disclosed.
Bain Capital and Cinven announced a definitive agreement to sell a majority stake in STADA Arzneimittel AG to CapVest Partners. Bain and Cinven intended to retain a minority stake after completion. The release expected completion in the first half of 2026 and did not establish a closing date.
An affiliate of Balmoral Funds acquired Wilbur-Ellis Nutrition, LLC from Wilbur-Ellis Holdings II, LLC. The acquired business was to operate as Rangen. A separate closing date was not stated.
Avery Dennison agreed to acquire Meridian Adhesives Group’s U.S. flooring adhesives business for $390 million, subject to adjustments. Arsenal remained an investor in Meridian after its 2022 partnership with American Securities. Closing was expected in the fourth quarter of 2025.
Terumo announced an agreement to acquire all outstanding shares of HealthQuest-backed OrganOx. The agreement was dated August 23, 2025 and announced on August 25; the source describes completion as prospective.
Eden Capital-backed Edcetera announced its acquisition of Pulse Radiology Institute on August 18, 2025, adding the institute’s degree programs to its existing radiology education offerings. The exact closing date was not reported.
Summit-backed Invicti Security reported its acquisition of application-security software provider Kondukto on August 14, 2025. The exact closing day and financial terms were not stated.
SBG Holdings, identified as a Charger Investment Partners portfolio company, announced on August 11, 2025 that it had partnered with management to complete the acquisition of Ameripolish. Clint Howle and Carl Cabot would continue to lead the business. Transaction terms and the exact closing date were not disclosed.
HistoSonics announced a management-led majority-stake acquisition by a consortium of investors. HealthQuest was identified among existing investors participating in the transaction. The source does not state HealthQuest’s purchased or sold percentage, and closing remained prospective.
Blackstone-affiliated private equity funds announced a definitive agreement to acquire Enverus from Hellman & Friedman and Genstar Capital. The source reports an agreement, with no closing date established.